Fifth Third Bancorp
AIMT

Fifth Third Bancorp’s Aimmune Therapeutics AIMT Stock Holding History

Fifth Third Bancorp’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-347
Closed -$12K – 2502
2020
Q3 		$12K Buy
347
+100
+40% +$2.13K ﹤0.01% 1728
2020
Q2 		$4K Hold
247
– – ﹤0.01% 1918
2020
Q1 		$4K Hold
247
– – ﹤0.01% 1921
2019
Q4 		$8K Sell
247
-290
-54% -$8.11K ﹤0.01% 1895
2019
Q3 		$11K Buy
537
+290
+117% +$5.92K ﹤0.01% 1785
2019
Q2 		$5K Sell
247
-2
-0.8% -$41 ﹤0.01% 2016
2019
Q1 		$6K Hold
249
– – ﹤0.01% 1919
2018
Q4 		$6K Buy
+249
New +$6.44K ﹤0.01% 1946

Fifth Third Bancorp's AIMT Position: Q4 2020 in Review

Fifth Third Bancorp sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 347 shares — an estimated $12K sold.

Fifth Third Bancorp first reported a position in AIMT in Q4 2018 and held it in 8 quarters. The position peaked at $12K in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

  • Fifth Third Bancorp reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Fifth Third Bancorp sold 347 Aimmune Therapeutics shares in Q4 2020, an estimated $12K.
  • Fifth Third Bancorp first reported a position in Aimmune Therapeutics in Q4 2018 and held it in 8 quarters.
  • Fifth Third Bancorp's Aimmune Therapeutics position peaked at $12K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Fifth Third Bancorp's 13F filing for Q4 2020, filed 16 Feb 2021.